RK
Ravi Kiran Bobba
About Ravi Kiran Bobba
Data last updated:
Ravi Kiran Bobba is a Director at American Cancer Care Private Limited (since 2022) and Director at Ugenomix Private Limited (since 2024). The companies operate in Healthcare. The largest current company by reported revenue is American Cancer Care Private Limited at ₹4.25 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 American Cancer Care Private Limited U85300AP2022PTC122223 | Director | 27 Jul 2022 | 2022 | ₹4.25 Cr (FY 2024) | Active |
| Ugenomix Private Limited U86905AP2024PTC115536 | Director | 30 Jul 2024 | 2024 | Active |
Board colleagues of Ravi Kiran Bobba
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kasturi Mata Bobba | 09669544 | American Cancer Care Private Limited , Ugenomix Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Kiran Bobba
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Kiran Bobba
Ravi Kiran Bobba currently holds 2 directorships: American Cancer Care Private Limited (Director, since 27 Jul 2022, revenue ₹4.25 Cr (FY 2024)); Ugenomix Private Limited (Director, since 30 Jul 2024).
Ravi Kiran Bobba was first appointed on 27 Jul 2022 as Director at American Cancer Care Private Limited. The most recent appointment on record is 30 Jul 2024 at Ugenomix Private Limited.
The current boards of Ravi Kiran Bobba's companies include Kasturi Mata Bobba (American Cancer Care Private Limited).